Responses
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
THU0150 Long-Term Safety and Efficacy of SB4 (Etanercept Biosimilar) in Patients with Rheumatoid Arthritis: Comparison between Continuing SB4 and Switching from Etanercept Reference Product To SB4
Compose a Response to This Article
Other responses
No responses have been published for this article.